Boston Scientific Corporation (BSX)
USD 87.57
(-2.37%)
USD 87.57
(-2.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 8.62 Billion USD | 3.27% |
| 2022 | 8.35 Billion USD | 11.0% |
| 2021 | 7.52 Billion USD | -3.57% |
| 2020 | 7.8 Billion USD | -22.42% |
| 2019 | 10.06 Billion USD | 46.14% |
| 2018 | 6.88 Billion USD | 27.72% |
| 2017 | 5.39 Billion USD | 1.93% |
| 2016 | 5.28 Billion USD | -1.31% |
| 2015 | 5.35 Billion USD | 45.8% |
| 2014 | 3.67 Billion USD | -8.65% |
| 2013 | 4.02 Billion USD | -0.64% |
| 2012 | 4.04 Billion USD | 1.38% |
| 2011 | 3.99 Billion USD | -23.56% |
| 2010 | 5.22 Billion USD | 3.38% |
| 2009 | 5.05 Billion USD | -0.98% |
| 2008 | 5.1 Billion USD | -24.24% |
| 2007 | 6.73 Billion USD | -6.87% |
| 2006 | 7.23 Billion USD | 517.24% |
| 2005 | 1.17 Billion USD | 9.43% |
| 2004 | 1.07 Billion USD | 1.61% |
| 2003 | 1.05 Billion USD | 60.18% |
| 2002 | 658 Million USD | -35.74% |
| 2001 | 1.02 Billion USD | 31.28% |
| 2000 | 780 Million USD | -35.75% |
| 1999 | 1.21 Billion USD | -47.69% |
| 1998 | 2.32 Billion USD | 432.95% |
| 1997 | 435.5 Million USD | 89.93% |
| 1996 | 229.3 Million USD | 621.14% |
| 1995 | -44 Million USD | 6.38% |
| 1994 | -47 Million USD | -85.77% |
| 1993 | -25.3 Million USD | 63.49% |
| 1992 | -69.3 Million USD | -459.07% |
| 1991 | 19.3 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 8.38 Billion USD | 10.17% |
| 2024 Q1 | 8.67 Billion USD | 0.52% |
| 2024 Q2 | 7.94 Billion USD | -8.35% |
| 2023 Q2 | 9.02 Billion USD | 2.65% |
| 2023 FY | 8.62 Billion USD | 3.27% |
| 2023 Q1 | 8.79 Billion USD | 5.28% |
| 2023 Q4 | 8.62 Billion USD | 3.35% |
| 2023 Q3 | 8.34 Billion USD | -7.54% |
| 2022 Q1 | 9.35 Billion USD | 24.34% |
| 2022 Q2 | 9.05 Billion USD | -3.28% |
| 2022 Q4 | 8.35 Billion USD | -2.82% |
| 2022 FY | 8.35 Billion USD | 11.0% |
| 2022 Q3 | 8.59 Billion USD | -5.03% |
| 2021 Q3 | 7.51 Billion USD | 10.65% |
| 2021 Q1 | 7.42 Billion USD | -4.84% |
| 2021 FY | 7.52 Billion USD | -3.57% |
| 2021 Q2 | 6.78 Billion USD | -8.59% |
| 2021 Q4 | 7.52 Billion USD | 0.19% |
| 2020 Q1 | 10.22 Billion USD | 1.66% |
| 2020 Q3 | 7.3 Billion USD | -9.37% |
| 2020 Q4 | 7.8 Billion USD | 6.79% |
| 2020 FY | 7.8 Billion USD | -22.42% |
| 2020 Q2 | 8.06 Billion USD | -21.14% |
| 2019 Q4 | 10.06 Billion USD | -5.06% |
| 2019 Q1 | 9.07 Billion USD | 31.8% |
| 2019 Q2 | 9.4 Billion USD | 3.63% |
| 2019 Q3 | 10.59 Billion USD | 12.7% |
| 2019 FY | 10.06 Billion USD | 46.14% |
| 2018 Q3 | 6.43 Billion USD | 2.83% |
| 2018 Q1 | 5.44 Billion USD | 0.98% |
| 2018 FY | 6.88 Billion USD | 27.72% |
| 2018 Q2 | 6.25 Billion USD | 14.88% |
| 2018 Q4 | 6.88 Billion USD | 7.06% |
| 2017 Q3 | 5.47 Billion USD | -2.98% |
| 2017 FY | 5.39 Billion USD | 1.93% |
| 2017 Q1 | 5.35 Billion USD | 1.32% |
| 2017 Q2 | 5.64 Billion USD | 5.26% |
| 2017 Q4 | 5.39 Billion USD | -1.5% |
| 2016 Q1 | 5.33 Billion USD | -0.35% |
| 2016 Q3 | 5.18 Billion USD | 3.99% |
| 2016 Q2 | 4.98 Billion USD | -6.56% |
| 2016 Q4 | 5.28 Billion USD | 1.93% |
| 2016 FY | 5.28 Billion USD | -1.31% |
| 2015 Q3 | 5.5 Billion USD | 30.89% |
| 2015 Q1 | 4.02 Billion USD | 9.55% |
| 2015 FY | 5.35 Billion USD | 45.8% |
| 2015 Q4 | 5.35 Billion USD | -2.74% |
| 2015 Q2 | 4.2 Billion USD | 4.55% |
| 2014 Q1 | 4.05 Billion USD | 0.87% |
| 2014 FY | 3.67 Billion USD | -8.65% |
| 2014 Q3 | 4 Billion USD | 2.77% |
| 2014 Q2 | 3.89 Billion USD | -3.94% |
| 2014 Q4 | 3.67 Billion USD | -8.26% |
| 2013 Q2 | 3.72 Billion USD | -6.62% |
| 2013 Q1 | 3.98 Billion USD | -1.56% |
| 2013 FY | 4.02 Billion USD | -0.64% |
| 2013 Q4 | 4.02 Billion USD | 9.38% |
| 2013 Q3 | 3.67 Billion USD | -1.18% |
| 2012 Q1 | 3.97 Billion USD | -0.48% |
| 2012 Q2 | 3.88 Billion USD | -2.24% |
| 2012 Q3 | 3.9 Billion USD | 0.44% |
| 2012 Q4 | 4.04 Billion USD | 3.74% |
| 2012 FY | 4.04 Billion USD | 1.38% |
| 2011 Q2 | 4.04 Billion USD | -6.51% |
| 2011 Q1 | 4.32 Billion USD | -17.15% |
| 2011 Q3 | 3.98 Billion USD | -1.48% |
| 2011 Q4 | 3.99 Billion USD | 0.18% |
| 2011 FY | 3.99 Billion USD | -23.56% |
| 2010 Q2 | 5.22 Billion USD | -3.33% |
| 2010 Q4 | 5.22 Billion USD | -3.47% |
| 2010 Q3 | 5.41 Billion USD | 3.66% |
| 2010 FY | 5.22 Billion USD | 3.38% |
| 2010 Q1 | 5.4 Billion USD | 6.89% |
| 2009 FY | 5.05 Billion USD | -0.98% |
| 2009 Q4 | 5.05 Billion USD | 8.71% |
| 2009 Q3 | 4.64 Billion USD | -8.05% |
| 2009 Q2 | 5.05 Billion USD | -5.5% |
| 2009 Q1 | 5.35 Billion USD | 4.82% |
| 2008 Q3 | 5.26 Billion USD | -7.09% |
| 2008 Q1 | 5.82 Billion USD | -13.48% |
| 2008 FY | 5.1 Billion USD | -24.24% |
| 2008 Q4 | 5.1 Billion USD | -3.09% |
| 2008 Q2 | 5.66 Billion USD | -2.74% |
| 2007 Q3 | 6.92 Billion USD | -6.36% |
| 2007 FY | 6.73 Billion USD | -6.87% |
| 2007 Q1 | 7.56 Billion USD | 4.58% |
| 2007 Q2 | 7.39 Billion USD | -2.31% |
| 2007 Q4 | 6.73 Billion USD | -2.64% |
| 2006 Q4 | 7.23 Billion USD | -1.67% |
| 2006 Q1 | 1.55 Billion USD | 33.02% |
| 2006 FY | 7.23 Billion USD | 517.24% |
| 2006 Q2 | 7.74 Billion USD | 396.54% |
| 2006 Q3 | 7.35 Billion USD | -4.96% |
| 2005 FY | 1.17 Billion USD | 9.43% |
| 2005 Q1 | 718 Million USD | -32.96% |
| 2005 Q2 | 1.35 Billion USD | 89.14% |
| 2005 Q3 | 1.76 Billion USD | 30.27% |
| 2005 Q4 | 1.17 Billion USD | -33.75% |
| 2004 Q3 | 954 Million USD | -26.1% |
| 2004 Q2 | 1.29 Billion USD | 21.79% |
| 2004 Q4 | 1.07 Billion USD | 12.26% |
| 2004 Q1 | 1.06 Billion USD | 0.57% |
| 2004 FY | 1.07 Billion USD | 1.61% |
| 2003 Q2 | 915 Million USD | -4.39% |
| 2003 Q3 | 1.1 Billion USD | 20.55% |
| 2003 Q4 | 1.05 Billion USD | -4.44% |
| 2003 FY | 1.05 Billion USD | 60.18% |
| 2003 Q1 | 957 Million USD | 45.44% |
| 2002 Q3 | 849 Million USD | -17.33% |
| 2002 Q4 | 658 Million USD | -22.5% |
| 2002 FY | 658 Million USD | -35.74% |
| 2002 Q1 | 1.04 Billion USD | 1.76% |
| 2002 Q2 | 1.02 Billion USD | -1.44% |
| 2001 FY | 1.02 Billion USD | 31.28% |
| 2001 Q2 | 1.06 Billion USD | 29.73% |
| 2001 Q4 | 1.02 Billion USD | -7.58% |
| 2001 Q3 | 1.1 Billion USD | 3.65% |
| 2001 Q1 | 824 Million USD | 5.64% |
| 2000 FY | 780 Million USD | -35.75% |
| 2000 Q1 | 1.12 Billion USD | -7.25% |
| 2000 Q4 | 780 Million USD | -4.29% |
| 2000 Q2 | 966 Million USD | -14.21% |
| 2000 Q3 | 815 Million USD | -15.63% |
| 1999 Q2 | 1.49 Billion USD | -31.37% |
| 1999 Q1 | 2.17 Billion USD | -6.2% |
| 1999 FY | 1.21 Billion USD | -47.69% |
| 1999 Q3 | 1.24 Billion USD | -16.47% |
| 1999 Q4 | 1.21 Billion USD | -2.72% |
| 1998 Q1 | 430 Million USD | -1.26% |
| 1998 FY | 2.32 Billion USD | 432.95% |
| 1998 Q3 | 2.44 Billion USD | 468.54% |
| 1998 Q4 | 2.32 Billion USD | -4.99% |
| 1998 Q2 | 429.7 Million USD | -0.07% |
| 1997 FY | 435.5 Million USD | 89.93% |
| 1997 Q1 | 198.4 Million USD | -13.48% |
| 1997 Q2 | 296.2 Million USD | 49.29% |
| 1997 Q3 | 361.5 Million USD | 22.05% |
| 1997 Q4 | 435.5 Million USD | 20.47% |
| 1996 Q4 | 229.3 Million USD | 37.64% |
| 1996 Q3 | 166.6 Million USD | -19.9% |
| 1996 Q2 | 208 Million USD | 298.47% |
| 1996 FY | 229.3 Million USD | 621.14% |
| 1996 Q1 | 52.2 Million USD | 218.64% |
| 1995 Q1 | -115.8 Million USD | -146.38% |
| 1995 Q2 | -116.6 Million USD | -0.69% |
| 1995 Q3 | -117.3 Million USD | -0.6% |
| 1995 Q4 | -44 Million USD | 62.49% |
| 1995 FY | -44 Million USD | 6.38% |
| 1994 Q1 | -38.6 Million USD | -52.57% |
| 1994 Q3 | -55.6 Million USD | -64.01% |
| 1994 Q2 | -33.9 Million USD | 12.18% |
| 1994 Q4 | -47 Million USD | 15.47% |
| 1994 FY | -47 Million USD | -85.77% |
| 1993 FY | -25.3 Million USD | 63.49% |
| 1993 Q4 | -25.3 Million USD | -91.67% |
| 1993 Q1 | -77.2 Million USD | -11.4% |
| 1993 Q2 | -20.7 Million USD | 73.19% |
| 1993 Q3 | -13.2 Million USD | 36.23% |
| 1992 Q1 | 34 Million USD | 76.17% |
| 1992 FY | -69.3 Million USD | -459.07% |
| 1992 Q3 | -102.1 Million USD | -13.19% |
| 1992 Q2 | -90.2 Million USD | -365.29% |
| 1992 Q4 | -69.3 Million USD | 32.13% |
| 1991 FY | 19.3 Million USD | 0.0% |
| 1991 Q4 | 19.3 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Abbott Laboratories | 8.97 Billion USD | 3.899% |
| Allurion Technologies Inc. | 3.82 Million USD | -225737.696% |
| Artivion, Inc. | 300.4 Million USD | -2771.828% |
| Avanos Medical, Inc. | 121.4 Million USD | -7006.26% |
| Butterfly Network, Inc. | -109.6 Million USD | 7970.704% |
| Butterfly Network, Inc. | -109.6 Million USD | 7970.704% |
| Bio-Rad Laboratories, Inc. | 1 Billion USD | -761.039% |
| CONMED Corporation | 966.95 Million USD | -792.179% |
| Edwards Lifesciences Corporation | -449.1 Million USD | 2020.953% |
| Paragon 28, Inc. | 36.39 Million USD | -23606.411% |
| Glaukos Corporation | 290.27 Million USD | -2872.05% |
| Globus Medical, Inc. | 53.11 Million USD | -16143.034% |
| Inspire Medical Systems, Inc. | -160.69 Million USD | 5468.689% |
| Integer Holdings Corporation | 1.01 Billion USD | -748.044% |
| Medtronic plc | 24.76 Billion USD | 65.162% |
| Myomo, Inc. | -6.27 Million USD | 137691.641% |
| Nevro Corp. | 117.61 Million USD | -7235.261% |
| Owlet, Inc. | -1.34 Million USD | 643426.356% |
| Penumbra, Inc. | 66.85 Million USD | -12803.66% |
| Vicarious Surgical Inc. | -37.99 Million USD | 22808.608% |
| Smith & Nephew plc | 2.78 Billion USD | -210.101% |
| Sonendo, Inc. | 26.34 Million USD | -32649.981% |
| STERIS plc | 3.17 Billion USD | -171.618% |
| Stryker Corporation | 10.02 Billion USD | 13.937% |
| Vapotherm, Inc. | 102.66 Million USD | -8302.895% |
| Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | -54.622% |